Delivery Order SPE2DB22D3019-SPE2DB25FK3ZY
Award Date 7/30/25
Potential Completion Date 7/31/25
Potential Value $24K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,831.88 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 20 mg, a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder. The award, issued on July 8, 2025, with an ultimate completion date of July 9, 2025, represents a firm fixed-price delivery order with no set-aside designation. This order was fulfilled from AmerisourceBergen's place of performance in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,328.29 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 10 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The award, issued on August 15, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 18, 2025. This contract was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $4,934.09 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 50 mg, a prescription medication commonly used to treat attention deficit hyperactivity disorder. This non-set-aside contract, awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a small-value pharmaceutical supply transaction typical of DLA's ongoing medical procurement operations. The performance location is...
- The Defense Logistics Agency awarded a delivery order valued at $1,634.42 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 10 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order was issued on August 26, 2025, with an ultimate completion date of August 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The...
- The Defense Logistics Agency awarded a delivery order valued at $7,637.24 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 10 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, was issued without a set-aside designation and represents a competitively awarded transaction. The pharmaceutical supplies will be...
- The Defense Logistics Agency awarded a $2,239.00 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 10 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The contract was competitively awarded without set-aside designation and is classified as a firm fixed price delivery order, with an ultimate completion date of August 25, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of...
- The Defense Logistics Agency awarded a $2,336.95 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 60 mg, a prescription medication commonly used to treat attention-deficit/hyperactivity disorder. The award was made on July 10, 2025, with an ultimate completion date of July 11, 2025, under a firm fixed-price contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, where the pharmaceutical products will be delivered, is a...
- The Defense Logistics Agency awarded a $3,163.85 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 50 mg, a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder. The contract, awarded on July 24, 2025, with completion targeted for July 25, 2025, carries a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. Performance will be fulfilled from AmerisourceBergen's location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,980.92 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 30 mg, a controlled substance commonly prescribed for attention deficit hyperactivity disorder. This non-set-aside, firm fixed-price delivery order was executed on August 27, 2025, with an ultimate completion date of August 28, 2025. The pharmaceutical products will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $3,848.78 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 70 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The contract was competitively awarded on September 12, 2025, with an ultimate completion date of September 15, 2025, and represents a firm fixed-price transaction with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves...